价格图

    PRALATREXATE

    • 电话报价

    分享

    描述

    Pralatrexate is a folate analogue metabolic inhibitor indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). This indication is based on overall response rate. Clinical benefit such as improvement in progression free survival or overall survival has not been demonstrated. INDICATION Treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). This indication is based on overall response rate.

    可显示的语言

    English
    پارسی
    中国
    Russian
    العربية
    Spanish
    Deutsch
    اردو
    Türkçe
    Français
    Italy
    Português
    Nederlands
    हिंदी
    Հայերեն
    请稍等片刻...